L'application de santé cardiaque qui pose enfin la bonne question

Il existe aujourd'hui des centaines d'applications pour la santé cardiaque sur le marché. La plupart d'entre elles font la même chose : elles surveillent votre fréquence cardiaque, suivent vos pas, mesurent votre sommeil et vous disent de manger plus de légumes. Certaines des plus sophistiquées se connectent à des objets connectés et vous donnent un affichage en temps réel de votre pouls. Quelques-unes signalent même un rythme cardiaque irrégulier.

Ce sont des outils utiles. Mais ils répondent tous à une question différente.

Les moniteurs de fréquence cardiaque vous disent ce que fait votre cœur en ce moment même. Ce qu'ils ne peuvent pas vous dire — ce qu'aucun appareil connecté à votre poignet ne peut vous dire — c'est ce que votre cœur est susceptible de faire dans dix, vingt ou trente ans, sur la base du plan génétique que vous avez hérité de votre famille. Cette question nécessite un tout autre type d'outil. Et jusqu'à présent, aucune application n'avait été conçue pour y répondre correctement.

Cela change aujourd'hui.

Présentation du calculateur de risque cardiaque

Le Cœur Calculateur de risque est désormais disponible sur Google Play et représente quelque chose de véritablement nouveau dans le domaine des applications de santé cardiaque. Ce n'est pas un moniteur de fréquence cardiaque. Ce n'est pas un podomètre. Ce n'est pas un minuteur de méditation ou un tension artérielle journal de bord. À notre connaissance, il s'agit de l'une des premières applications grand public conçues spécifiquement pour quantifier le risque cardiovasculaire héréditaire à l'aide d'un cadre d'évaluation pondéré des antécédents familiaux — le Coefficient de danger hérédité — tiré de principes établis dans la littérature évaluée par les pairs publiée en Trafic, JAMA, le European Heart Journal, et le Lancette. ^{[1],[2],[3],[4]}

L'idée fondamentale de cette application est simple mais profonde : votre histoire familiale ce n'est pas une question par oui ou par non.

Les calculateurs de risque cardiaque standard, y compris celui largement utilisé Score de risque de Framingham — demander si vous avez des antécédents familiaux de maladies cardiaques. ^[1] Oui ou non. C'est tout. Un grand-parent mourant d'un crise cardiaque à 82 ans et avec un frère ou une sœur qui s'effondre de mort subite d'origine cardiaque à 39, les deux obtiennent la même case à cocher. Ce n'est pas la même chose. Même de loin. Et la recherche est sans équivoque à ce sujet. ^[3],[5]

Ce qui rend cette application différente

Il demande qui, pas seulement si

Le calculateur de risque cardiaque organise l'historique cardiaque de votre famille par relation, âge lors de l'événement et gravité de l'issue. Un événement fatal chez un parent au premier degré Un événement survenu à l'âge de 40 ans véhicule un signal héréditaire fondamentalement différent de celui d'un événement non mortel survenu chez un grand-parent à l'âge de 75 ans. L'application rend compte mathématiquement de cette différence, en utilisant un cadre de pondération fondé sur des données probantes, développé par Peter Megdal, PhD à partir d'observations épidémiologiques publiées :

H = Σ (R × W) / A

Où R est le coefficient de relation (0,5 pour les parents et la fratrie, 0,25 pour les grands-parents, tantes et oncles), W est le poids de gravité de l'événement cardiaque, et A est l'âge auquel l'événement est survenu. L'équation est un cadre pédagogique fondé sur des données probantes qui combine des principes de risque épidémiologique établis en un score structuré — fournissant une estimation structurée du risque cardiaque familial héréditaire qu'aucun questionnaire standard ne peut saisir.

Il révèle le Piège d'imagerie

L'une des conclusions les plus importantes — et les plus alarmantes — de la recherche cardiovasculaire récente est ce que les cliniciens appellent le piège de l'imagerie. Une coronaire standard Artère Le score calcique, l'un des outils de dépistage les plus couramment utilisés en cardiologie, peut donner un score de zéro alors même que des plaques molles dangereuses, plaque non calcifiée se développe activement dans vos artères. ^[6] Pour les personnes présentant un risque cardiaque héréditaire important, un score calcique de zéro peut fournir une fausse assurance chez certains patients.

L'essai randomisé CAUGHT-CAD de 2025 a confirmé que chez les patients ayant des antécédents familiaux de maladie coronarienne précoce, Angiographie coronaire par TDM peut identifier des lésions non calcifiées plaque non détecté par le score calcique et pouvant influencer la prise en charge chez certains patients. ^[7] Le calculateur de risque cardiaque est conçu sur la base de cette recherche. Il vous aide à comprendre si vos antécédents familiaux peuvent vous situer parmi les personnes pour qui une discussion supplémentaire avec un médecin concernant les options d'imagerie pourrait être appropriée.

Il capture ce que les objets connectés ratent complètement

Votre Apple Watch connaît votre fréquence cardiaque au repos. Elle ne sait pas que votre frère a fait une crise cardiaque fatale à 42 ans. Votre Fitbit suit la qualité de votre sommeil. Il ne peut pas vous dire qu'un frère ou une sœur atteint d'une maladie cardiaque précoce confère un odds ratio de 2,46 pour votre propre risque cardiaque — un chiffre documenté dans des recherches évaluées par des pairs publiées dans JAMA. ^[5] Votre Garmin mesure VO2 max. Il n'a aucun moyen de rendre compte de la charge héréditaire additive — ce que les chercheurs appellent le dosage génique — qui se produit lorsque plusieurs proches développent une forme précoce maladie cardiovasculaire, augmentant considérablement la probabilité d'une prédisposition génétique héréditaire. ^[3],[8]

Les objets connectés mesurent ce qui se passe dans votre corps en ce moment même. Le calculateur de risque cardiaque modélise le signal familial héréditif qui se reflète dans vos antécédents familiaux et ce qu'il suggère quant à votre trajectoire cardiaque tout au long de la vie. Les objets connectés et les outils basés sur les antécédents familiaux fournissent des informations complémentaires mais différentes — pourtant, un seul d'entre eux aide à identifier les personnes qui pourraient bénéficier d'une évaluation plus approfondie que celle proposée par le dépistage standard.

Cela vous donne matière à apporter à votre médecin

Chaque résultat du calculateur de risque cardiaque est conçu comme un point de départ pour une discussion, et non comme une conclusion. L'application génère un résumé des antécédents familiaux prêt à être discuté et un ensemble de questions spécifiques et cliniquement fondées que vous pouvez poser lors de votre prochain rendez-vous. Des questions telles que : étant donné mes antécédents familiaux, pourrais-je avoir plaque molle qu'un scanner calcique standard raterait ? Devrais-je être orienté vers un cardiologue préventif plutôt que d'être pris en charge en soins primaires ? Mes antécédents familiaux modifient-ils la façon dont les outils d'évaluation du risque standard doivent être interprétés dans mon cas ? ^[9]

These are the questions that can genuinely change the course of a clinical encounter. They are the questions that turn a routine annual physical into a meaningful cardiovascular conversation. And they are the questions that most people never know to ask — because no one has ever organized their family history in a way that makes those questions visible.

It Is Built on Real Science

The Heart Risk Calculator is not a wellness app built on general advice. The concepts incorporated into its framework are informed by more than 40 peer-reviewed publications spanning inherited cardiac risk, premature maladie coronarienne, family history epidemiology, et le génétique of cardiovascular susceptibility. The gene dosing model underlying the Inherited Hazard Coefficient draws on foundational research in inherited cardiovascular disease published in Nature Reviews Cardiology, le Lancette, et le European Heart Journal. ^[4],[8] The parental and sibling risk data come from landmark studies in JAMA et Trafic. ^[3],[5] The clinical significance of early cardiac events in close relatives — and the inadequacy of standard tools in capturing that significance — is documented across decades of cardiovascular epidemiology. ^[9]

This is not an algorithm someone built in a weekend. It is an evidence-informed educational framework, developed as an educational tool by Peter Megdal, PhD, that applies established epidemiologic principles to a problem that standard tools have never been designed to solve.

Why This Matters Right Now

Heart disease remains the number one cause of death in the United States. ^[10] Roughly half of all Americans have a family history of cardiac events. ^[11] And yet the tools available to most people for understanding their inherited risk remain remarkably primitive — a checkbox on an intake form, a Framingham score that was never designed to capture genetic loading, ^[1] and a calcium scan that may miss the most dangerous plaque entirely in younger, gene-dosed individuals. ^[6],[9]

For a 20-year-old whose sibling died of sudden cardiac death at 38, the Framingham Risk Score will often return a ten-year risk of under one percent — because the formula is driven by chronological age, not inherited biology. ^[1] That person’s inherited risk profile may warrant substantially more evaluation than suggested by conventional calculators. And without a tool that models the inherited familial signal in their family history, they will never know to ask the right questions until it is too late.

The Heart Risk app exists for that person. It exists for everyone who has sat in a doctor’s office and said “yes, there’s heart disease in my family” and watched that information disappear into a checkbox that changes nothing about their care.

Download It Today

The Heart Risk Calculator app is available now on Google Play for $4.99. It is an educational tool, not a medical device, and it does not replace clinical evaluation. But it may be the most important five dollars you spend on your heart health — not because it monitors your pulse, but because it finally asks the question that wearables and standard calculators have never been designed to answer.

Your family history is data. It’s time to use it.

This tool is for educational purposes only and does not constitute medical advice. The score has not been prospectively validated for predicting individual cardiovascular events and should not be used to diagnose disease. Always consult a qualified healthcare professional before making health decisions. Research by Peter Megdal, PhD — CuringHeartDisease.com

References

1. D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753. doi:10.1161/CIRCULATIONAHA.107.699579.
2. Virani SS, Alonso A, Aparicio HJ, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743. doi:10.1161/CIR.0000000000000950
3. Lloyd-Jones DM, Nam BH, D’Agostino RB Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291(18):2204-2211. doi:10.1001/jama.291.18.2204
4. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-2472. doi:10.1093/eurheartj/ehx144
5. Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA. 2005;294(24):3117-3123. doi:10.1001/jama.294.24.3117
6. Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry. J Am Coll Cardiol. 2011;58(24):2533-2540. doi:10.1016/j.jacc.2011.10.851
7. Nerlekar N, Vasanthakumar SA, Whitmore K, et al. Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease: A Randomized Clinical Trial. JAMA. 2025;333(16):1403-1412. doi:10.1001/jama.2025.0584
8. Bachmann JM, Willis BL, Ayers CR, Khera A, Berry JD. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study. Circulation. 2012;125(25):3092-3098. doi:10.1161/CIRCULATIONAHA.111.065490
9. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. doi:10.1161/CIR.0000000000000678
10. Martin SS, Aday AW, Allen NB, et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025;151(8):e41-e660. doi:10.1161/CIR.0000000000001303
11. Moonesinghe R, Yang Q, Zhang Z, Khoury MJ. Prevalence and Cardiovascular Health Impact of Family History of Premature Heart Disease in the United States: Analysis of the National Health and Nutrition Examination Survey, 2007-2014. J Am Heart Assoc. 2019;8(14):e012364. doi:10.1161/JAHA.119.012364

---

Addendum

Evidentiary Basis for the Inherited Hazard Coefficient Algorithm

Companion document to: “The Heart Health App That Finally Asks the Right Question”

Overview

The Inherited Hazard Coefficient (IHC) is computed using the formula:

H = Σ (R × W) / A

Where R is the relation coefficient (0.5 for first-degree relatives: parents and siblings; 0.25 for second-degree relatives: grandparents, aunts, and uncles), W is the severity weight of the cardiac event, A is the age at which the event occurred, and Σ represents summation across all affected relatives in the family history.

Each structural element of this formula — the relation coefficient R, the severity weight W, the age denominator A, and the summation logic — is grounded in a specific body of peer-reviewed cardiovascular epidemiology. This addendum identifies the primary literature supporting each component and distinguishes that evidence from the design choices that represent the author’s own evidence-informed synthesis.

The R Term: Relation Coefficient

The R term encodes the degree of biological relatedness between the patient and the affected family member. First-degree relatives (parents, siblings) receive a coefficient of 0.5, reflecting the 50% shared genome. Second-degree relatives (grandparents, aunts, uncles) receive 0.25, reflecting 25% shared genome. The differential weighting of first- versus second-degree relatives is supported by two landmark Framingham-based studies.

Lloyd-Jones et al., JAMA 2004

^[1] This prospective Framingham offspring analysis was among the first to rigorously confirm parental cardiovascular disease as an independent predictor of offspring CVD after full adjustment for conventional facteurs de risque. Critically, the study demonstrated that risk compounded when both parents were affected — the conceptual foundation for the summation structure of the IHC. The paper directly supports the assignment of the 0.5 coefficient to parents and the differential weighting of first-degree versus second-degree relatives.

Murabito et al., JAMA 2005

^[2] This companion Framingham sibling analysis documented an unadjusted odds ratio of 2.46 for cardiovascular disease in individuals with an affected sibling — a magnitude comparable to or exceeding that of parental history in certain subgroups. This finding is the primary justification for assigning siblings the same R coefficient of 0.5 as parents, rather than a lower value. It also reinforced the core principle that first-degree relatives constitute a categorically different risk tier from second-degree relatives.

The A Term: Age at Event in the Denominator

The A term places the age at which the family member experienced their cardiac event in the denominator of the formula, so that younger events produce a higher IHC contribution. This is the most clinically consequential structural feature of the algorithm and is supported by consistent findings across multiple data sources.

Lloyd-Jones et al., JAMA 2004 and Murabito et al., JAMA 2005

^[1],[2] Both Framingham analyses stratified their findings by age at the family event and demonstrated substantially elevated risk when the cardiac event was premature — defined as occurring before age 55 in male relatives and before age 65 in female relatives. A family event at age 40 carries a fundamentally different inherited signal than the same event at age 78. The A term in the denominator is a direct mathematical encoding of this well-established epidemiologic principle.

D’Agostino et al., Circulation 2008 — Framingham Risk Score

^[3] Cited in the main article as the primary example of a risk calculator that does pas account for age at the family event. The Framingham score uses the patient’s own chronological age as its dominant driver of 10-year risk, but incorporates no variable for the age at which family members experienced cardiac events. The A denominator in the IHC formula is specifically designed to correct for this gap — capturing what the Framingham score systematically omits.

The W Term: Severity Weight

The W term assigns differential weights to cardiac events based on their severity — with fatal events, sudden cardiac death, and early revascularization receiving higher weights than medically managed non-fatal events. This reflects the well-documented relationship between event severity and underlying atherosclerotic burden.

Villines et al., JACC 2011 — CONFIRM Registry

^[4] This large multicenter CCTA registry demonstrated that even among patients with a CAC score of zero — conventionally considered low risk — a meaningful proportion harbored non-calcified, potentially obstructive plaque. The study provided strong evidence that event severity and plaque characteristics are not uniform across patients with nominally similar risk profiles. Fatal events in first-degree relatives imply a higher inherited charge athéromateuse and more aggressive disease trajectory than non-fatal, medically managed events — the epidemiologic rationale for the W severity weighting.

Nerlekar et al., JAMA 2025 — CAUGHT-CAD Trial

^[5] This 2025 randomized trial in patients with a family history of premature CAD demonstrated that non-calcified plaque burden varied substantially even among individuals within the same broad family history category. The trial used CCTA to quantify plaque progression as its primary endpoint, confirming that severity differentiation within the inherited risk spectrum has measurable clinical significance — and is not captured by binary family history classification or calcium scoring alone.

The Σ Term: Summation Across Relatives

The summation operator reflects the principle that inherited cardiac risk compounds with each additional affected relative. A patient with two affected first-degree relatives carries a meaningfully different inherited signal than a patient with one. The Σ structure encodes this dose-response relationship mathematically.

Bachmann et al., Circulation 2012 — Cooper Center Longitudinal Study

^[6] This large prospective study of men followed over decades demonstrated that family history of maladie coronarienne death was associated with significantly elevated long-term cardiovascular mortality, and that the risk accumulated across the follow-up period in a manner consistent with an underlying dose-response relationship. The study supports the logic of summing contributions across affected relatives rather than treating family history as a single binary flag.

Ference et al., European Heart Journal 2017

^[7] This Randomisation mendélienne analysis demonstrated that the atherogenic effect of cholestérol LDL — the primary driver of inherited lipid-related cardiac risk — is cumulative and time-dependent. Lifetime exposure to elevated LDL produces atherosclerotic burden that is proportional to the integral of exposure over time, not simply to any single measurement. This biological framework supports the IHC summation structure: inherited cardiovascular risk is not a point estimate but a cumulative signal that should be aggregated across all affected relatives and weighted by the severity and timing of their events.

What the Literature Validates — and What It Does Not

What is validated

The peer-reviewed literature cited above establishes the following with high confidence:

• First-degree relatives confer greater inherited cardiac risk than second-degree relatives.
• Siblings carry risk comparable to parents, not intermediate between parents and grandparents.
• The age at which a family member experienced a cardiac event is a critical variable: premature events confer dramatically greater inherited signal than late-life events.
• Multiple affected relatives compound inherited risk in a dose-response fashion.
• Event severity correlates with underlying atherosclerotic burden and is not uniform across family history reports.
• Standard risk calculators systematically underutilize this information, particularly in younger patients with strong family histories.

What is not validated

The existing literature does pas validate:

• The specific coefficient values chosen for R (0.5 and 0.25).
• The specific severity weight values assigned to W.
• The mathematical form of dividing by A rather than applying a categorical age-at-event modifier.
• The formula H = Σ(R×W)/A as a clinically calibrated predictive score for individual cardiovascular event risk.
• The IHC against any prospective outcome dataset.

The IHC formula is an evidence-informed educational framework that translates established epidemiologic principles into a structured, quantitative estimate of inherited familial cardiac risk. The inputs are grounded in landmark peer-reviewed literature. The specific mathematical implementation — the coefficient values, the weighting scheme, and the formula structure — represents the author’s synthesis of those principles and has not been independently validated. The ACC/AHA Primary Prevention Guideline ^[8] explicitly recognizes family history as a risk-enhancing factor that should modify clinical decision-making, but stops short of providing a quantitative formula for doing so. The IHC is designed to fill precisely that gap.

References

1. Lloyd-Jones DM, Nam BH, D’Agostino RB Sr, et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA. 2004;291(18):2204-2211. doi:10.1001/jama.291.18.2204
2. Murabito JM, Pencina MJ, Nam BH, et al. Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA. 2005;294(24):3117-3123. doi:10.1001/jama.294.24.3117
3. D’Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117(6):743-753. doi:10.1161/CIRCULATIONAHA.107.699579
4. Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry. J Am Coll Cardiol. 2011;58(24):2533-2540. doi:10.1016/j.jacc.2011.10.851
5. Nerlekar N, Vasanthakumar SA, Whitmore K, et al. Effects of Combining Coronary Calcium Score With Treatment on Plaque Progression in Familial Coronary Artery Disease: A Randomized Clinical Trial. JAMA. 2025;333(16):1403-1412. doi:10.1001/jama.2025.0584
6. Bachmann JM, Willis BL, Ayers CR, Khera A, Berry JD. Association between family history and coronary heart disease death across long-term follow-up in men: the Cooper Center Longitudinal Study. Circulation. 2012;125(25):3092-3098. doi:10.1161/CIRCULATIONAHA.111.065490
7. Ference BA, Ginsberg HN, Graham I, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J. 2017;38(32):2459-2472. doi:10.1093/eurheartj/ehx144
8. Arnett DK, Blumenthal RS, Albert MA, et al. 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):e596-e646. doi:10.1161/CIR.0000000000000678